These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7667509)

  • 21. [Dystrophin detection by immunofluorescent technique for diagnosing muscular dystrophy].
    Wang X; Xie Y; Zhang C; Liu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):239-42. PubMed ID: 12048687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlative MR imaging and 31P-MR spectroscopy study in sarcoglycan deficient limb girdle muscular dystrophy.
    Lodi R; Muntoni F; Taylor J; Kumar S; Sewry CA; Blamire A; Styles P; Taylor DJ
    Neuromuscul Disord; 1997 Dec; 7(8):505-11. PubMed ID: 9447608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular energetics of dystrophic muscle.
    Kemp GJ; Taylor DJ; Dunn JF; Frostick SP; Radda GK
    J Neurol Sci; 1993 Jun; 116(2):201-6. PubMed ID: 8393092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated phosphodiester and T
    Hooijmans MT; Niks EH; Burakiewicz J; Verschuuren JJ; Webb AG; Kan HE
    NMR Biomed; 2017 Jan; 30(1):. PubMed ID: 27859827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The mechanism of muscle fiber breakdown in Duchenne muscular dystrophy--with particular reference to the significance of opaque muscle fibers].
    Uchino M; Araki S; Yoshida O
    Rinsho Shinkeigaku; 1985 Aug; 25(8):944-8. PubMed ID: 4064436
    [No Abstract]   [Full Text] [Related]  

  • 26. [Association between dystrophin and neuronal nitric oxide synthase in muscles of progressive muscular dystrophy].
    Wang S; Shen D
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):155-7. PubMed ID: 11953148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [MR-tomography and -spectroscopy of skeletal muscles using high magnetic field strengths].
    Rodiek SO; Küther G; Juretschke HP; Hoepfel D; Schuff N
    Rofo; 1986 Jan; 144(1):89-95. PubMed ID: 3003848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [NMR-CT in muscular disorders: muscle T1 values in Duchenne muscular dystrophy carriers].
    Matsumura K; Nakano I; Fukuda N; Ikehira H; Tateno Y
    Rinsho Shinkeigaku; 1987 Feb; 27(2):237-43. PubMed ID: 3581601
    [No Abstract]   [Full Text] [Related]  

  • 29. In vivo proton magnetic resonance spectroscopy assessment for muscle metabolism in neuromuscular diseases.
    Hsieh TJ; Wang CK; Chuang HY; Jong YJ; Li CW; Liu GC
    J Pediatr; 2007 Sep; 151(3):319-21. PubMed ID: 17719948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI of normal and pathologic skeletal muscle.
    Murphy WA; Totty WG; Carroll JE
    AJR Am J Roentgenol; 1986 Mar; 146(3):565-74. PubMed ID: 3484872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-dimensional MR imaging of brain surface anomalies in Fukuyama-type congenital muscular dystrophy.
    Toda T; Watanabe T; Matsumura K; Sunada Y; Yamada H; Nakano I; Mannen T; Kanazawa I; Shimizu T
    Muscle Nerve; 1995 May; 18(5):508-17. PubMed ID: 7739638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 31P-NMR studies of normal and dystrophic chicken muscle.
    Pettegrew J; Minshew N; Feit H
    Muscle Nerve; 1984; 7(6):442-6. PubMed ID: 6543898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscle metabolism in Duchenne muscular dystrophy assessed by in vivo proton magnetic resonance spectroscopy.
    Hsieh TJ; Jaw TS; Chuang HY; Jong YJ; Liu GC; Li CW
    J Comput Assist Tomogr; 2009; 33(1):150-4. PubMed ID: 19188804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spatially localized phosphorous metabolism of skeletal muscle in Duchenne muscular dystrophy patients: 24-month follow-up.
    Hooijmans MT; Doorenweerd N; Baligand C; Verschuuren JJGM; Ronen I; Niks EH; Webb AG; Kan HE
    PLoS One; 2017; 12(8):e0182086. PubMed ID: 28763477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MR spectroscopy of the heart.
    Sardanelli F; Quarenghi M
    Radiol Med; 2006 Dec; 111(8):1025-34. PubMed ID: 17171530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Exploration of exercise intolerance by 31P NMR spectroscopy of calf muscles coupled with MRI and ergometry].
    Laforêt P; Wary C; Duteil S; de Kerviler E; Carlier PG; Lombès A; Romero NB; Fardeau M; Eymard B; Leroy-Willig A
    Rev Neurol (Paris); 2003 Jan; 159(1):56-67. PubMed ID: 12618654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duchenne muscular dystrophy: MR grading system with functional correlation.
    Liu GC; Jong YJ; Chiang CH; Jaw TS
    Radiology; 1993 Feb; 186(2):475-80. PubMed ID: 8421754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Merosin-negative congenital muscular dystrophy: magnetic resonance spectroscopy findings.
    Aslan M; Alkan A; Yakinci C; Sonmezgoz E; Bicak U; Zorludemir S
    Brain Dev; 2005 Jun; 27(4):308-10. PubMed ID: 15862197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative NMRI and NMRS identify augmented disease progression after loss of ambulation in forearms of boys with Duchenne muscular dystrophy.
    Wary C; Azzabou N; Giraudeau C; Le Louër J; Montus M; Voit T; Servais L; Carlier P
    NMR Biomed; 2015 Sep; 28(9):1150-62. PubMed ID: 26215733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of the interference pattern in patients with muscular dystrophy].
    Escobar-Cedillo RE; Miranda A; Lona S; Castillo M
    Rev Neurol; 2004 Sep 16-30; 39(6):517-20. PubMed ID: 15467987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.